Related Information

New Trade Deal Would Benefit Big Pharma At AIDS Programs' Expense

According to leaked documents from the talks, U.S. negotiators are seeking to impose a set of restrictive intellectual property laws that would help American drug companies secure long-term monopolies overseas. The result? Higher prices for drugs. That's good for corporate profits, but disastrous for relief programs like PEPFAR that depend on cheaper generic medications to treat the global poor.

Submission by American Apparel & Footwear Association

This is a presentation by American Apparel & Footwear Association on “Achieving 21st Century Terms of Trade for Apparel and Footwear in the TPP” and "TPP Apparal Coalition" at Stakeholders’ Forum, held at the sidelines of the 7th Round of the TPP in Ho Chi Minh City.